Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type
Clinical trial NCT05477264 · RECRUITING
Trial details
- NCT number
- NCT05477264
- Sponsor
- Won Seog Kim
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-02
- Primary completion
- 2026-12-31
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.